chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Positive for COVID-19; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of COVID-19 (Positive for COVID-19) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2020, the patient experienced COVID-19 (Positive for COVID-19). The patient was treated with ASA ongoing since an unknown date at a dose of UNK daily; MULTIVITAMINS [VITAMINS NOS] ongoing since an unknown date at a dose of UNK daily and STEROIDS ongoing since an unknown date at a dose of UNK daily. At the time of the report, COVID-19 (Positive for COVID-19) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Dec-2020, Polymerase chain reaction: (Positive) Patient tested positive for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient experienced symptoms headache, muscle ache, loss of smell, loss of taste. Concomitant medications details were not reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 29-Mar-2021: The patient's current condition, symptoms, event outcome and treatment information were provided.; Sender's Comments: Based on lack of biological implausibility  the event is assessed as unlikely related to mRNA-1273.
Initially hot shooting pains in calves 6 hours after first shot.  Within 36 hours hot, burning pain and tenderness in hands and feet, especially strong in left hand. Then a bunch of broken blood vessels in palm and fingers of left hand lasting more than a week.  Nerve pain continued for three weeks in left hand and soles of feet. After 4 weeks I reluctantly got 2nd shot which resulted in intense hand tenderness and nerve pain mostly on left hand and left foot.  At about three weeks after 2nd shot, developed  hot, burning (nerve?) pain like fire under the skin of my chest and stomach that would come in waves.  This lasted about a month, currently not happening.  In the past 2 weeks (3 months post 2nd shot) the pain and tenderness in my left hand has increased dramatically and begun to ache.  Cannot grip, grab or touch most things with my left hand without pain.  Sometimes I see the blue vessels come close to the skin on  left hand where they were broken after 1st shot.  Some neuropathy remains in the sole and toes of my left foot as well.
Patient with complaints of chest pain and nausea. Seen in ER. EKG normal, nausea resolved. Gastritis medication prescribed.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender who on unknown dates were vaccinated with improperly stored doses of ZOSTAVAX (dose, route, lot # and expiration date were not provided). No adverse experiences were reported. This is one of several reports received from the same reporter. Additional information has been requested.
CPhT did not dilute the vaccine with 2.2ml NaCL 0.9% and administered 0.2ml dose directly from the undiluted vaccine vial.  Left a voicemail for parents to call Rx back.  Will counsel patient of possible side effects.  Also, will contact PCP once PCP information obtained.
Fever of 100 F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 100 F) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Historical condition not reported.).    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PYREXIA (Fever of 100 F). On 03-Apr-2021, PYREXIA (Fever of 100 F) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to -MODERNATX, INC.-MOD-2021-073761 (E2B Linked Report).; Sender's Comments:  -MODERNATX, INC.-MOD-2021-073761:wife case
I woke up with fever and sore throat, generally ickyness; I went to the doctor because my husband has tested positive 2 days before, and they tested for strep throat, flu, covid-19 and I was positive for Covid-19 and I had an ear infection, he prescribed medicine as well and PAXLOVID for the COVID-19. I took it for 7 days.
INJECTION SITE, LEFT ARM, LEFT SHOULDER SWELLING. INABILITY TO USE LEFT ARM AND LEFT LEG. HIGH FEVER (104). EXTREME SHIVERING. INABLILITY TO STAND AND WALK. CARDIAC ARREST. PATIENT WAS RESUSCITATED, TREATED AT HOSPITAL, TRANSFERRED TO ANOTHER HOSPITAL REMAINED IN ICU UNTIL 8-18-2018 AND IS CURRENTLY REMAINS IN HOSPITAL.
Patient called the day after shot to say that 2 hrs after giving shot he experienced tightness and pressure across the chest.  He took BP and pulse-BP 124/70 Pulse 130-  state symptoms are minor today.
1) Headache all over 2) Body aches all over 3) Vomiting 4) Nausea 5) Fever
Within 4 hours of receiving the vaccine I was nauseous with chills fever onset, body aches and extreme fatigue. Within the next 24 hrs I had a fever of 102, body aches, chills where I couldn't stop shaking, sore arm at injection site. It was the worse I had felt in a very long time. I called my on call physician on Saturday. He gave no treatment other than rest, fluids and Tylenol. I slept the entire weekend after receiving the vaccine on Friday. I had fatigue for about 2 weeks after the shot. In March, I was still fatigued, my ankles were also significantly swollen and difficulty breathing like wheezing at the end of March. I had a significant asthma event I had a course of prednisone. My normal inhalers were not working. I also used medicated breathing treatments, nebulizer. Also, in March,  I had the worst menstrual cycle. I had significant cramps and heavy bleeding both of which were unusual. In April and forward, it was back to normal.  My ankles and breathing are back to normal.
Large knot about 4 inches down from site of injection.  Red and hot to touch.  Injection site with red rash at insertion site and rash around site. These symptoms lasted about 4 days. No treatment other than Tylenol and ice packs.
Resident began experiencing T100.2, decreased to 98.8 after tylenol, chills, body aches, increasing pain in both shoulder/nek and warm/red face.
Began with tingling sensation in both calf muscles in legs the day after the shot. Then primarily in the right calf for several days, a tingling, pulsing sensation but not painful. Since the 19th it has been tingling in both lower legs again and on the 20th it also started tingling in the left arm.
PNEUMOVAX inj. subQ given in (L) arm at 3:30 pm 04/23/13. Patient assistant 1 episode of vomiting in evening on 04/23. assistant erythema at site, increasing in size. Patient advised to go to ER/Urgent Care. Patient went to clinic on 04/24/13. Put on antibiotics, cold compress, anti-inflammatories.
The morning after the shot, major body and headaches with a low fever. Today, 2 days after the shot and one day after reaction- I?m totally back to normal.
Two hours after receiving the injection on 3/2/21, I could not abduct or flex my left arm without extreme pain. Pain that is 7 out of 10 on the pain scale. It decreased the next day with ice and Tylenol but then returned exactly 7 days later on  3/9/21 even worse.  As of day of reporting on 3/11/21, the pain is still present.
SHORTNESS OF BREATH AND TIGHTNESS OF CHEST.  1ST EMERGENCY ROOM VISIT PATIENT WAS SENT HOME DISAGNOSED WITH ANXIETY DISORDER. SOB AND TIGHTNESS CONTINUES DURING FOLLOWING WEEKS. PATIENT RETURNS FOR 2ND VISIT AT SAME EMERGENCY ROOM AT UNION HOSPITAL WITH SEVERE SHORTNESS OF BREATH. CAT SCAN OF LUNGS AND ULTRASOUND OF LEG REVEALLED MULTIPLE BLOOD CLOTS IN BOTH LUNGS AND BEHIND KNEE. PATIENT WAS ADMITTED TO HOSPITAL. PATIENT WAS PLACED ON IV BLOOD THINNERS DURING STAY. PATIENT WAS RELEASED ON ELIQUIS.
I was ill/sick for three weeks.  I am currently going through menopause and have hot flashes frequently throughout the day; not with the Covid shot.  I was freezing cold.  I had 4 fleece blankets on plus wool pajamas.  Four nights I had to sleep in a recliner because it felt like there was an elephant on my chest and I could not breathe.  Two mornings I was coming to work, left my driveway and threw up all over myself; had to turn around, take a shower, and come into work, only to only be able to work 2-4 hours per day for 3 weeks.  The Sat. and Sun. following the injection, I slept until Mon. morning.  I had pure exhaustion from the shot.
PATIENT has received both PFIZER covid vaccine doses 01/14/2021 and 02/04/2021. TESTED POSITIVE TO COVID.
Hospitalization: 12/21/2022 - 12/23/2022 (2 days) Presentation to the ED: generalized body pain along with nausea, epigastric burning, pain in her back, and diffuse upper abd pain.  COVID + date: 12/21/2022 Treatment: no treatment. patient was afebrile and not hypoxic.  Discharge to: Home.   Pfizer EW186 5/23/2021 Pfizer LOEW0186 6/13/2021
can breath to will; arm hurt; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (can breath to will) and MYALGIA (arm hurt) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (can breath to will) and MYALGIA (arm hurt). At the time of the report, DYSPNOEA (can breath to will) and MYALGIA (arm hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No Treatment information was reported   Reporter did not allow further contact
Body aches; chills; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches) and CHILLS (chills) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal and Allergy NOS.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Body aches) and CHILLS (chills). At the time of the report, MYALGIA (Body aches) and CHILLS (chills) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medications reported included unspecified blood pressure medication and medication for allergies. No treatment medications provided by the reporter.    Reporter did not allow further contact
Vomiting , Fever Rectal Temp 103, gave Tylenol fever reducer on 9/14/2020 two to three hours after immunizations fevers were aggressive between 102 to 103. Called advice nurse 9/15/2020 recommend continue fever reducer every 4 to 5 hours to reduce fevers. On 9/16/2020 fevers were still consistent advice nurse and doctor recommended come to ER. ER visit diagnosed Pnuemonia from X-Ray. At discharge prescribed Amoxicillin 8ml two times a day, fevers continued between 102 and 103 rectal temps.  Chronic Fevers, Limp, Inactive, Non Verbal, Thighs Swelling 9/14/2020 to 9/19/2020 on and off. Chronic Fevers stopped 9/18/2020 started back up 9/20/2020 to 9/22/2020. Treatment at hospital admission 9/21/2020 to 9/23/2020 IV applied, still chronic fevers but they stopped on 8/23/2020 after IV treatment and consistent Tylenol around the clock and discharged after 24 hours no fever on 9/23/2020 around 1:00 pm. Doctor's stated that it was a mystery they don't know why fevers where going on.
after receiving the 2nd dose 24 hrs later I felt whoozy, feverish and took some Acetom aminophen one capsule, and felt better for few hours and around 4pm  I felt feverish again and a bit dizzy, took another Acetaminophen Put icy compresses on my forehead, and still feel warmish. I can function, no problem
Information regarding Prevnar was received from a physician regarding a 15 month old female who received a dose of Prevnar and subsequently developed hemolytic-uremic syndrome and pneumococcal pneumonia. The patient's concurrent illness includes a history of mild asthma. Indication for Prevnar was immunization. Product was administered on an unspecified date. Dose regimen was 1 dose (IM). Concomitant medications were not reported. Four days before admission, a 15 month old infant was seen by her pediatrician for cough, fever, and wheezing. She was treated with inhaled steroids. The following day, she was again evaluated by the pediatrician who ordered a chest x-ray with the results of right lung pneumonia. She was then admitted. A chest computerized tomogram and ultrasound were performed and confirmed pneumonia. A urine latex AG was performed and the results indicated urine pneumococcal antigen positive. Day 2 of hospitalization, video-assisted thoracoscopic surgery was performed; results were not provided. The reporter indicated that there were no complications of surgery. Treatment consisted of cefuroxime, azithromycin, methylprednisolone and ampicillin sodium/sulbactam. Day 3 of hospitalization brought sudden death. Laboratory tests performed at resuscitation were: hemoglobin, 0.6 g/dL; platelet count, 20,000; white blood cell count 18,000. The autopsy reported cause of death was hemolytic-uremic syndrome. The reporter indicated that this was related to likely pneumococcal infection. No additional information was available at the time of this report.
slumped over bathroom sink; could not communicate or move; could not communicate or move; felt cold and clammy; whole upper body (including head) was spasming/contracting; felt drugged; fatigue; sore arm/extreme soreness; This spontaneous case was reported by a nurse and describes the occurrence of FALL (slumped over bathroom sink), HYPOKINESIA (could not communicate or move), COMMUNICATION DISORDER (could not communicate or move), COLD SWEAT (felt cold and clammy) and MUSCLE SPASMS (whole upper body (including head) was spasming/contracting) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017C21A and 047B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Back surgery in 2009. Concomitant products included CENTRUM FORTE for an unknown indication.   On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-May-2021, the patient experienced FATIGUE (fatigue) and VACCINATION SITE PAIN (sore arm/extreme soreness). On 20-May-2021, the patient experienced FALL (slumped over bathroom sink), HYPOKINESIA (could not communicate or move), COMMUNICATION DISORDER (could not communicate or move), COLD SWEAT (felt cold and clammy), MUSCLE SPASMS (whole upper body (including head) was spasming/contracting) and FEELING ABNORMAL (felt drugged). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form. On 20-May-2021, FALL (slumped over bathroom sink), HYPOKINESIA (could not communicate or move), COMMUNICATION DISORDER (could not communicate or move), COLD SWEAT (felt cold and clammy), MUSCLE SPASMS (whole upper body (including head) was spasming/contracting) and FEELING ABNORMAL (felt drugged) had resolved. On 22-May-2021, FATIGUE (fatigue) and VACCINATION SITE PAIN (sore arm/extreme soreness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 116/70 (normal) 116/70. On an unknown date, Heart rate: 72 (normal) 72. On an unknown date, Oxygen saturation: 99 % (normal) 99.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-176770 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up received on 21 JUL 2021: No new information. On 21-Jul-2021: NNI
51 year old male with no significant history except depression taking Celexa for years.  Had routine lab work December 2020 at primary doctor which was normal.  Started feeling headache and lethargy week of 6/7/2021, one month after second dose of Pfizer Covid Vaccine.  Initially treated with steroids and antibiotics by primary physician for supposed sinus infection.  Symptoms progressively got worse with loss of appetite, vomiting and diarrhea.  Primary physician then started course of Levaquin with no relief.  CXR and Covid test ordered and results Negative.  Patient admitted to hospital on 7/2/21 with diagnosis of ARF .   Creatine 12.74.
High fever, constipation, inconsolable crying, fussiness, gastrointestinal distress and pain. Duration 5 days. Weakened immune system.
This spontaneous report has been received from a pharmacist referring to a patient of unknown age and gender. On 03-DEC-2015 the patient was vaccinated with ZOSTAVAX (dose and route not reported, lot # L021610, expired date: 10-SEP-2016) which was an improperly stored vaccine. No adverse effect reported. Additional information has been requested.
High fever, vomiting, SPLITTING headache and slept a lot. Thank the lord.
Inappropriate age at vaccine administration; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     No medical history was reported.     On 20-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. No treatment was reported. Action taken in response to mRNA-1273 was not applicable.
The patient presented back to the pharmacy on 5/30/18 reporting a significant reaction she had incurred from the SHINGRIX vaccine. Her left deltoid had significant bruising at the injection site (dark purple and blue) about the size of golf ball (circumference). She also had pictures of redness and swelling that she had experienced on 5/27 and 5/28 on the lower half of her humerus as well as at the injection site. She reported significant pain in her left arm to the extent that she could not use it or move it without significant discomfort. The patient said she self-treated with ice and over the counter allegra (dose and quantity unknown). Today, 5/30/18, the bruising is still very apparent, however the redness and swelling seem to have subsided and the paient said shes more comfortable now.
Significant increase in apnea, bradycardia, disaturations beginning PM of 8/24/03 after vaccines given. The discharge summary received on 2/2/04 states UTI.
MA reported an adverse event on a vaccine administered to a patient  that was later found to be stored in a freezer; vaccine was later found to be in a freezer that had insufficient data reported with data logger and a previous temperature excursion was found supported; This spontaneous report has been received from a medical assistant concerning a 4-year-old patient of unknown gender. The patient's concurrent conditions, known allergies/reactions, medical history and concomitant medications were not reported.   On 08-SEP-2020, an adverse event was reported on the administration of an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) 0.5 milliliter, lot # T005404, expiration date 12-AUG-2020 (route of administration not reported) as prophylaxis.  It was also reported that the improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot # T005404 expiration date 12-AUG-2020; rHa albumin status) experienced an unknown temperature during an unspecified amount of time accompanied with another dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot # T013536, expiration date 17-AUG-2021, albumin status rHa) and with a dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot # S032355 with expiration date reported as 05-JUL-2022 but upon internal validation established as 14-OCT-2021). This doses were later found to be stored in a freezer that had insufficient data reported with a data logger, and had a previous temperature excursion of 6 degree Fahrenheit (°F) to 14°F (average temperature was 8.6°F) for 25 minutes. The call was due a digital data logger. The outcome of the adverse event was not reported.  The causal relationship between the adverse event and Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot # T005404 expiration date 12-AUG-2020) was unknown.
fever and flu like symptoms; fever and flu like symptoms; This is a spontaneous report from a contactable other health care professional (patient). A 67-years-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Batch/Lot Number: EN6202, Expiry date : not reported), via intramuscular route of administration in Deltoid Left on 24Feb2021 11:15 (at the age of 67-years) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included hypothyroidism from 2013 to an unknown date. Concomitant medications included levothyroxine sodium (SYNTHROID, Formulation, Batch/Lot Number and Expiry date : not reported) taken via oral route of administration for hypothyroidism from 2003 and ongoing. The patient did not receive any prior vaccinations. The patient has received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Batch/Lot Number: EN7534, Expiry date : not reported), via intramuscular route of administration in Deltoid Left on 17Mar2021 14:30 as DOSE 2, SINGLE for covid-19 immunisation. On 24Feb2021 15:30, the patient experienced fever and flu like symptoms. No initiation of new medication/other treatment/procedure was reported was required for event. Relevant test was reported as none. The outcome of the events was recovered on 01Mar2021. Follow-up attempts completed. No further information expected.
Injection site infection. Treated with Oral steroids' and antibiotics for swelling/pain and infection
2 days after the vaccine my left arm pit lymph nodes grew VERY large and painful about the size of a tennis ball sliced in half. I also experience numerous episodes of fevers and sweating. The next day (3 days post vaccine), I developed a large red rash reaction at the injection site on my left arm. It was the circumference of a tennis ball and was hard, hot to the touch, and very painful. There was also a burning sensation.  Today is the 3rd day post vaccine so I don?t have information about how long this will last. Feel free to contact me for a follow up. I just wanted to get this info out there to those that need it.
Patient reports evening after flu vaccine had fever of 102 and was talking out of her head. Symptoms lasted for 2 days.